股票 › PTGX
主角治疗 PTGX
美股市值排名 #1585
$132.04 −$3.22 (-2.38%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $132.04 0.00%
开盘$135.26
昨收$135.26
当日区间$128.00 – $138.40
成交量972.9K
市值$8.54B
市盈率（TTM）27.9
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$213.48M+3,749.2% YoY
营业利润$158.77M+477.6% YoY
净利润$162.85M+568.3% YoY
摊薄每股收益$2.29+516.4% YoY
自由现金流$218.88M+839.6% YoY
经营现金流$219.05M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率20.7%
净利率29.4%
净资产收益率11.0%
资产收益率10.3%
投入资本回报率7.5%
流动比率21.71
负债/资产比率5.0%
现金及投资$782.58M
总负债$6.82M
净现金（净负债）$775.76M
自由现金流/营收46.3%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $213.48M | $56.37M | $46.02M | $7.44M | $4.71M |
| 营业总收入 | $213.48M | $56.37M | $46.02M | $7.44M | $4.71M |
| 营业费用 | $54.71M | $60.02M | $204.14M | $57.79M | $51.13M |
| 销售及管理费用 | $12.65M | $13.28M | $44.85M | $11.43M | $11.13M |
| -管理费用 | $12.65M | $13.28M | $44.85M | $11.43M | $11.13M |
| 研发费用 | $42.06M | $46.74M | $159.29M | $46.36M | $40.00M |
| 营业利润 | $158.77M | -$3.65M | -$158.13M | -$50.36M | -$46.42M |
| 非经营性利息净收入（支出） | $6.43M | $5.88M | $28.79M | $6.76M | $7.05M |
| 非经营性利息收入 | $6.43M | $5.88M | $28.79M | $6.76M | $7.05M |
| 其他收入（支出） | -$81,000.00 | $53,000.00 | $27,000.00 | -$124,000.00 | $33,000.00 |
| 其他非经营性收入（支出） | -$81,000.00 | $53,000.00 | $27,000.00 | -$124,000.00 | $33,000.00 |
| 税前利润 | $165.11M | $2.28M | -$129.31M | -$43.72M | -$39.34M |
| 税费 | $2.27M | -$1.50M | $838,000.00 | $666,000.00 | $0.00 |
| 净利润 | $162.85M | $3.78M | -$130.15M | -$44.38M | -$39.34M |
| 持续经营利润 | $162.85M | $3.78M | -$130.15M | -$44.38M | -$39.34M |
| 归属母公司净利润 | $162.85M | $3.78M | -$130.15M | -$44.38M | -$39.34M |
| 归属普通股股东净利润 | $162.85M | $3.78M | -$130.15M | -$44.38M | -$39.34M |
| 基本每股收益 | $2.47 | $0.06 | -$2.05 | -$0.69 | -$0.62 |
| 摊薄每股收益 | $2.29 | $0.05 | -$2.05 | -$0.69 | -$0.62 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $885.54M | $697.46M | $668.19M | $668.19M | $701.69M |
| 流动资产合计 | $807.15M | $613.46M | $577.57M | $577.57M | $586.42M |
| 现金及现金等价物与短期投资 | $782.58M | $547.79M | $567.36M | $567.36M | $576.12M |
| -现金及现金等价物 | $420.08M | $193.71M | $128.39M | $128.39M | $113.71M |
| -短期投资 | $362.50M | $354.07M | $438.97M | $438.97M | $462.40M |
| 应收款 | $19.64M | $57.12M | $4.50M | $4.50M | $5.33M |
| -应计应收利息 | $2.86M | $3.46M | $4.37M | $4.37M | $4.55M |
| -一年内应收关联方款项 | $13.42M | $53.66M | $121,000.00 | $121,000.00 | $583,000.00 |
| -其他应收款 | $3.37M | – | $10,000.00 | $10,000.00 | $191,000.00 |
| 预付资产 | $2.62M | $3.99M | $5.71M | $5.71M | $4.98M |
| 其他流动资产 | $2.31M | $4.56M | – | – | – |
| 非流动资产合计 | $78.40M | $84.00M | $90.61M | $90.61M | $115.26M |
| 固定资产净值 | $10.40M | $11.17M | $11.69M | $11.69M | $12.27M |
| -固定资产原值 | $19.52M | $19.89M | $20.00M | $20.00M | $20.21M |
| -累计折旧 | -$9.12M | -$8.72M | -$8.32M | -$8.32M | -$7.94M |
| 投资及预付款 | $66.88M | $72.55M | $78.64M | $78.64M | $102.70M |
| 其他非流动资产 | $1.12M | $288,000.00 | $287,000.00 | $287,000.00 | $287,000.00 |
| 负债合计 | $44.00M | $41.99M | $53.48M | $53.48M | $56.25M |
| 流动负债合计 | $37.18M | $34.55M | $45.44M | $45.44M | $44.94M |
| 应付款 | $3.63M | $8.94M | $5.52M | $5.52M | $5.84M |
| -应付账款 | $3.46M | $8.44M | $5.34M | $5.34M | $5.65M |
| -其他应付款 | $175,000.00 | $502,000.00 | $185,000.00 | $185,000.00 | $190,000.00 |
| 一年内应计费用 | $15.85M | $12.76M | $15.32M | $15.32M | $15.15M |
| 短期债务及融资租赁负债 | $2.40M | $2.34M | $2.28M | $2.28M | $2.23M |
| -一年内到期融资租赁负债 | $2.40M | $2.34M | $2.28M | $2.28M | $2.23M |
| 一年内递延负债 | $9.66M | $6.28M | $9.55M | $9.55M | $14.20M |
| 非流动负债合计 | $6.82M | $7.44M | $8.04M | $8.04M | $11.31M |
| 长期债务及融资租赁负债 | $6.82M | $7.44M | $8.04M | $8.04M | $8.52M |
| -长期融资租赁负债 | $6.82M | $7.44M | $8.04M | $8.04M | $8.52M |
| 股东权益合计 | $841.54M | $655.47M | $614.71M | $614.71M | $645.44M |
| 股东权益 | $841.54M | $655.47M | $614.71M | $614.71M | $645.44M |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.15B | $1.12B | $1.08B | $1.08B | $1.07B |
| 留存收益 | -$304.04M | -$466.89M | -$470.67M | -$470.67M | -$426.29M |
| 不影响留存收益的损益 | -$828,000.00 | -$269,000.00 | $641,000.00 | $641,000.00 | $525,000.00 |
| -应付税款合计 | – | – | $0.00 | $0.00 | $0.00 |
| 一年以上递延负债 | – | – | $0.00 | $0.00 | $2.79M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $219.05M | -$48.94M | $57.67M | -$36.98M | -$1.94M |
| 持续经营经营活动现金流净额 | $219.05M | -$48.94M | $57.67M | -$36.98M | -$1.94M |
| 持续经营净利润 | $162.85M | $3.78M | -$130.15M | -$44.38M | -$39.34M |
| 折旧、折耗与摊销 | $397,000.00 | $407,000.00 | $1.28M | $376,000.00 | $361,000.00 |
| 其他非现金项目 | $440,000.00 | $439,000.00 | $1.58M | $337,000.00 | $101,000.00 |
| 营运资金变动 | $42.37M | -$67.06M | $146.21M | -$2.67M | $28.06M |
| -应收款变动 | $36.88M | -$53.54M | $164.88M | $462,000.00 | $21.70M |
| -预付资产变动 | $4.22M | -$1.92M | -$2.36M | -$365,000.00 | $50,000.00 |
| -应付账款及应计费用变动 | -$710,000.00 | -$7.79M | $5.61M | $5.10M | $9.96M |
| -其他流动负债变动 | -$560,000.00 | -$547,000.00 | -$903,000.00 | -$426,000.00 | -$581,000.00 |
| -其他营运资金变动 | $3.38M | -$3.27M | -$21.02M | -$7.44M | -$3.08M |
| 投资活动现金流净额 | -$2.43M | $90.89M | -$49.33M | $48.82M | -$58.56M |
| 持续经营投资活动现金流净额 | -$2.43M | $90.89M | -$49.33M | $48.82M | -$58.56M |
| 固定资产购置及出售净额 | -$168,000.00 | -$215,000.00 | -$1.59M | -$144,000.00 | -$88,000.00 |
| 投资购置及出售净额 | -$2.26M | $91.11M | -$47.74M | $48.96M | -$58.47M |
| 筹资活动现金流 | $9.74M | $23.37M | $22.86M | $2.84M | $5.66M |
| 持续经营筹资活动现金流净额 | $9.74M | $23.37M | $22.86M | $2.84M | $5.66M |
| 股票期权行使所得 | $9.74M | $23.37M | $23.34M | $2.84M | $5.66M |
| 期末现金余额 | $420.37M | $194.00M | $128.68M | $128.68M | $114.00M |
| 现金净变动 | $226.37M | $65.32M | $31.20M | $14.68M | -$54.83M |
| 期初现金余额 | $194.00M | $128.68M | $97.47M | $114.00M | $168.83M |
| 自由现金流 | $218.88M | -$49.16M | $56.08M | -$37.12M | -$2.03M |
| 持续经营损益 | – | -$2,000.00 | – | – | – |
| 普通股发行净额 | – | – | $0.00 | – | – |
| 其他筹资费用净额 | – | – | -$479,000.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 PTGX。
登录后参与讨论。